Literature DB >> 30714960

Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population.

Bibek Gyanwali1,2, Muhammad Amin Shaik1,3, Boon Yeow Tan4, Narayanaswamy Venketasubramanian5, Christopher Chen1,2, Saima Hilal1,2,6.   

Abstract

BACKGROUND: Cerebral small vessel disease (SVD) is one of the major contributors to cognitive impairment and dementia. However, data on the incidence and progression of SVD in an Asian population are lacking.
OBJECTIVE: The present study aims to investigate the incidence, progression, associated risk factors, and clinical relevance of SVD in a memory clinic setting.
METHODS: A prospective case-control study, where 346 patients underwent repeated brain MRI with a mean interval of 24.5 months, accessing white matter hyperintensities (WMH), lacunes and cerebral microbleeds (CMBs). Severity of cognitive impairment was assessed using Clinical Dementia Rating scale and change in clinical diagnosis. Data on demographics, vascular risk factors, and clinical history were collected at baseline.
RESULTS: The prevalence of significant WMH (Fazekas ≥2) was 56.6% at baseline which progressed to 59.0% at follow-up. Overall prevalence of CMBs increased from 42.2% to 47.4% (9% new cases) and lacunes increased from 31.8% to 33.2% (2.1% new cases). Hypertension was associated with WMH progression (OR: 1.78, 95% CI: 1.01, 2.99) and increasing age was associated with incident CMBs (OR: 1.04, 95% CI: 1.01, 1.08). Moreover, the use of lipid-lowering medications decreased the incidence of lacunes (OR: 0.15, 95% CI: 0.04, 0.61). The major risk factor for incident SVD was baseline SVD lesion load. WMH progression was associated with increased severity of cognitive impairment (OR: 1.95, 95% CI: 1.16, 3.23).
CONCLUSION: Vascular risk factors and baseline severity of SVD lesion load were associated with progression of SVD. Furthermore, WMH progression was linked with increased severity of cognitive impairment. Future studies should be aimed to slow cognitive deterioration by preventing SVD related brain damage by targeting vascular risk factors.

Entities:  

Keywords:  Cerebral small vessel disease; clinical dementia rating; cognitive impairment; magnetic resonance imaging; vascular risk factors

Mesh:

Year:  2019        PMID: 30714960     DOI: 10.3233/JAD-180911

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

1.  The protective effects of hyperoside on Ang II-mediated apoptosis of bEnd.3 cells and injury of blood-brain barrier model in vitro.

Authors:  Yu Yan Xie; Yun Wei Lu; Gu Ran Yu
Journal:  BMC Complement Med Ther       Date:  2022-06-13

2.  Study on the Interaction between the Characteristics of Retinal Microangiopathy and Risk Factors for Cerebral Small Vessel Disease.

Authors:  Qian Tang; Yanli Zhang; Zhengfang Yang; Siou Li; Meini Wu; Yongming Guo; Weina Zhao; Changhao Yin
Journal:  Contrast Media Mol Imaging       Date:  2022-06-09       Impact factor: 3.009

3.  White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.

Authors:  Yiwei Xia; Yi Shen; Yi Wang; Lumeng Yang; Yiqing Wang; Yu Li; Xiaoniu Liang; Qianhua Zhao; Jianjun Wu; Shuguang Chu; Zonghui Liang; Xiaoxiao Wang; Bensheng Qiu; Hansheng Ding; Ding Ding; Xin Cheng; Qiang Dong
Journal:  Aging (Albany NY)       Date:  2020-05-10       Impact factor: 5.682

4.  Suffering from Cerebral Small Vessel Disease with and without Metabolic Syndrome.

Authors:  Tatjana Bošković Matić; Gordana Toncev; Aleksandar Gavrilović; Dejan Aleksić
Journal:  Open Med (Wars)       Date:  2019-06-11

5.  Mixed-location cerebral microbleeds as a biomarker of neurodegeneration in a memory clinic population.

Authors:  Bibek Gyanwali; Muhammad Amin Shaik; Chuen Seng Tan; Henri Vrooman; Narayanaswamy Venketasubramanian; Christopher Chen; Saima Hilal
Journal:  Aging (Albany NY)       Date:  2019-11-25       Impact factor: 5.682

Review 6.  Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment.

Authors:  Vismitha Rajeev; David Y Fann; Quynh Nhu Dinh; Hyun Ah Kim; T Michael De Silva; Mitchell K P Lai; Christopher Li-Hsian Chen; Grant R Drummond; Christopher G Sobey; Thiruma V Arumugam
Journal:  Theranostics       Date:  2022-01-16       Impact factor: 11.556

7.  Quantitative Water Permeability Mapping of Blood-Brain-Barrier Dysfunction in Aging.

Authors:  Jeremy N Ford; Qihao Zhang; Elizabeth M Sweeney; Alexander E Merkler; Mony J de Leon; Ajay Gupta; Thanh D Nguyen; Jana Ivanidze
Journal:  Front Aging Neurosci       Date:  2022-04-08       Impact factor: 5.702

Review 8.  Advances in the Role of Endothelial Cells in Cerebral Small Vessel Disease.

Authors:  Tao Bai; Shijia Yu; Juan Feng
Journal:  Front Neurol       Date:  2022-04-11       Impact factor: 4.003

9.  Patterns of progression of cerebral small vessel disease markers in older adults of Amerindian ancestry: a population-based, longitudinal prospective cohort study.

Authors:  Oscar H Del Brutto; Robertino M Mera; Aldo F Costa; Denisse A Rumbea; Bettsy Y Recalde; Victor J Del Brutto
Journal:  Aging Clin Exp Res       Date:  2022-08-23       Impact factor: 4.481

10.  The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer's disease.

Authors:  Yu-Wen Cheng; Ming-Jang Chiu; Ya-Fang Chen; Ting-Wen Cheng; Ya-Mei Lai; Ta-Fu Chen
Journal:  Alzheimers Res Ther       Date:  2020-08-04       Impact factor: 6.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.